Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocytedeficient mice reconstituted with human NK cells
Keywords:
Materias Investigacion::Ciencias de la Salud::Inmunología
NK cells
ADCC
Multiple myeloma
CD137
Daratumumab
Publisher:
Informa UK Limited
Citation:
Ochoa, M.C. (María Carmen); Perez-Ruiz, E. (Elisabeth); Minute, L. (Luna); et al. "Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocytedeficient mice reconstituted with human NK cells". OncoImmunology. 8 (7), 2019, e1599636
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.